InMed Pharmaceuticals (INM) Q1 2025 Earnings
INM·Reported May 12, 2025·Before market open
InMed Pharmaceuticals reported Q1 2025 revenue of $1.8M (+108.1% YoY). Diluted EPS came in at $-1.94 (+46.1% YoY).
Revenue
$1.8M
Diluted EPS
$-1.94
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about InMed Pharmaceuticals's Q1 2025 earnings report.
InMed Pharmaceuticals (INM) reported Q1 2025 earnings on May 12, 2025 before market open.
InMed Pharmaceuticals reported revenue of $1.8M and diluted EPS of $-1.94 for Q1 2025.
Compared to the same quarter a year prior, revenue grew 108.1% from $863.5K a year earlier and diluted EPS grew 46.1% from $-3.60.
You can read the 10-Q periodic report (0001213900-25-042126) directly on SEC EDGAR. The filing index links above go to sec.gov.